Cited by 106Mesenchymal stem cell researchWound Healing and TreatmentsCytokine Signaling Pathways and Interactions

The role of Interleukin 1 receptor antagonist in mesenchymal stem cell‐based tissue repair and regeneration

Harrell, Carl Randall, Markovic, Bojana Simovic, Fellabaum, Crissy, Arsenijevic, Nebojsa, Djonov, Valentin, Volarevic, Vladislav·2020·BioFactors

Abstract

Interleukin (IL)‐1 receptor antagonist (IL‐1Ra), a naturally occurring antagonist of IL‐1α/IL‐1β signaling pathways, has been attributed to the immunosuppressive effects of mesenchymal stem cells (MSCs). MSCs, in IL‐1Ra‐dependent manner, suppressed production of IL‐1β in dermal macrophages, induced their polarization in anti‐inflammatory M2 phenotype, attenuated antigen‐presenting properties of dendritic cells (DCs), and promoted expansion of immunosuppressive T regulatory cells in the skin, which resulted in enhanced repair of the nonhealing wounds. Reduced activation of inflammasome and suppressed production of IL‐1β in macrophages were mainly responsible for beneficial effects of MSC‐derived IL‐1Ra in alleviation of acute lung injury, dry eye syndrome, and corneal injury. Through the production of IL‐1Ra, MSCs reduced migration of DCs to the draining lymph nodes and attenuated generation of inflammatory Th1 and Th17 cells that resulted in alleviation of fulminant hepatitis and rheumatoid arthritis. MSCs, in IL‐1Ra‐dependent manner, reduced liver fibrosis by suppressing production of Type I collagen in hepatic stellate cells. IL‐1Ra was, at least partially, responsible for enhanced proliferation of hepatocytes and chondrocytes in MSC‐treated animals with partial hepatectomy and osteoarthritis. Despite of these beneficial effects, IL‐1Ra‐dependent inhibition of IL‐1α/IL‐1β‐signaling significantly increased risk of infections. Therefore, future experimental and clinical studies should delineate potential side effects of MSC‐derived IL‐1Ra before IL‐1Ra‐overexpressing MSCs could be used as a potentially new therapeutic agent for the treatment of acute and chronic inflammatory diseases.

Integrity signals

Registry

Crossref · 10.1002/biof.1587

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-1RA-producing MSCs completely revert lung inflammation in mice by suppressing production of IL-1α, IL-1β and TNF-α by alveolar macrophages.

    “In fact, IL-1RA-producing MSCs has completely reverted lung inflammation in mice by suppressing production of IL-1α, IL-1β and TNF-α by alveolar macrophages [74], [175].”
  • There are several studies revealing beneficial effects of MSCs in lung fibrosis and acute lung injury.

    “There are several studies revealing the beneficial effects of MSCs in lung fibrosis and acute lung injury [74], [171], [172], [173], [174], [175], [176], [177], [178] (Fig. 4).”

Cites

Flagged first, then by citations

3 of the 86 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Harrell, C. R., Markovic, B. S., Fellabaum, C., Arsenijevic, N., Djonov, V., & Volarevic, V.
Affiliations
  • Regenerative Processing Plant, LLC Palm Harbor Florida
  • Faculty of Medical Sciences, Department for Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research University of Kragujevac Kragujevac Serbia
  • University of Bern (CH)
  • University of Kragujevac (RS)
Corresponding author
Volarevic, Vladislav
Venue
BioFactors
Publisher
Wiley
Published
2019-11-22
Volume
46
Issue
2
Pages
263-275
ISSN
  • 0951-6433 (ISSN-L)
  • 1872-8081
OpenAlex
W2990592352
Cited by
106
References
86
Citations by year
2026: 7 · 2025: 10 · 2024: 30 · 2023: 15 · 2022: 21 · 2021: 19 · 2020: 4
FWCI
1.35
Type
journal article
Language
en
Open access
closed
Locations
  • BioFactors (publishedVersion)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
interleukin-1 receptor antagonist, mesenchymal stem cells, IL-1β signaling, immunosuppression, macrophage polarization, M2 macrophages, dendritic cells, regulatory T cells, chronic wounds, acute lung injury, dry eye, corneal injury, fulminant hepatitis, rheumatoid arthritis, liver fibrosis, hepatic stellate cells, osteoarthritis, partial hepatectomy, infection risk, tissue regeneration
MeSH terms
Humans, Regeneration, Cell Proliferation, Interleukin 1 Receptor Antagonist Protein, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review